Why the study?
Does heparin or N-acetylheparin reduce myocardial infarct size in an in vivo canine model of myocardial ischaemia and reperfusion injury?
Does heparin or N-acetylheparin reduce myocardial infarct size in an in vivo canine model of myocardial ischaemia and reperfusion injury?
Heparin and N-acetylheparin reduce myocardial infarct size in a canine model of ischaemia-reperfusion injury, likely through mechanisms independent of anticoagulation.
No takes yet. Share an insight, caveat, or question.
May indicate non-anticoagulant cardioprotection in reperfusion injury; leaves open translation to human therapy.
Black et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: